Peer-Reviewed Journal Details
Mandatory Fields
Sardanelli, F;Boetes, C;Borisch, B;Decker, T;Federico, M;Gilbert, FJ;Helbich, T;Heywang-Kobrunner, SH;Kaiser, WA;Kerin, MJ;Mansel, RE;Marotti, L;Martincich, L;Mauriac, L;Meijers-Heijboer, H;Orecchia, R;Panizza, P;Ponti, A;Purushotham, AD;Regitnig, P;Del Turco, MR;Thibault, F;Wilson, R
2010
May
European Journal Of Cancer
Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group
Published
WOS: 411 ()
Optional Fields
CARCINOMA-IN-SITU CONTRAST-ENHANCED MRI BRCA2 MUTATION CARRIERS HIGH FAMILIAL RISK LYMPH-NODE BIOPSY NEOADJUVANT CHEMOTHERAPY IMPLANT RUPTURE CANCER PATIENTS CONSERVING SURGERY RESIDUAL DISEASE
46
1296
1316
The use of breast magnetic resonance imaging (MRI) is rapidly increasing. EUSOMA organised a workshop in Milan on 20-21st October 2008 to evaluate the evidence currently available on clinical value and indications for breast MRI. Twenty-three experts from the disciplines involved in breast disease management - including epidemiologists, geneticists, oncologists, radiologists, radiation oncologists, and surgeons - discussed the evidence for the use of this technology in plenary and focused sessions. This paper presents the consensus reached by this working group. General recommendations, technical requirements, methodology, and interpretation were firstly considered. For the following ten indications, an overview of the evidence, a list of recommendations, and a number of research issues were defined: staging before treatment planning; screening of high-risk women; evaluation of response to neoadjuvant chemotherapy; patients with breast augmentation or reconstruction; occult primary breast cancer; breast cancer recurrence; nipple discharge; characterisation of equivocal findings at conventional imaging; inflammatory breast cancer; and male breast. The working group strongly suggests that all breast cancer specialists cooperate for an optimal clinical use of this emerging technology and for future research, focusing on patient outcome as primary end-point. (C) 2010 Elsevier Ltd. All rights reserved.
0959-8049
10.1016/j.ejca.2010.02.015
Grant Details
Publication Themes